Arkema announces an investment plan of some $ 343 million over five years in the biosourced polyamide 11 chain, which is used in particular in automotive, 3D-printing, and in consumer goods markets such as sports and electronics.
Colombes Cedex/France — According to the company, this investment will enable the group to increase its polyamide 11 global production capacities (powder and granule) by 50 %.
Over the next five years, the group plans to invest in a world-scale plant dedicated to producing Rilsan PA11 biosourced polyamide from castor oil in Asia. The new plant, which will produce both the amino 11 monomer and its polymer, should come on stream in late 2021.
The investment also includes a 50 % increase in global production capacities for Pebax, in particular Pebax R-New of which amino 11 is a key component. Pebax R-New is a biosourced polyamide elastomer with properties such as energy return and flexibility, earmarked in particular for the sports and electronics markets, the company claims.
With this upcoming plant, the company will have a second amino 11 monomer production site, complementing its existing site in Marseille, France.